Literature DB >> 1712738

Microsurgical management of neovascularisation secondary to posterior segment ischaemia.

D McLeod1.   

Abstract

Structural, metabolic and functional rehabilitation of eyes affected by the haemorrhagic and tractional sequelae of neovascularisation secondary to posterior segment ischaemia is discussed. Microsurgical management must pay due attention not only to the mechanical but also to the underlying cell-biological implications of the surgical pathology. The appropriateness of case selection for surgery rests upon the likelihood of successful technical and functional outcomes and also upon the overall visual status of the patient, issues of particular relevance to diabetes.

Entities:  

Mesh:

Year:  1991        PMID: 1712738     DOI: 10.1038/eye.1991.40

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  7 in total

1.  Silicone oil in diabetic vitrectomy.

Authors:  D McLeod
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

2.  Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment.

Authors:  J Fernando Arevalo; Martin A Serrano; Juan D Arias
Journal:  World J Diabetes       Date:  2014-10-15

3.  Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.

Authors:  Morteza Entezari; Alireza Ramezani; Hamid Ahmadieh; Pejman Bakhtiari; Mehdi Yaseri; Kian Soltani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-25       Impact factor: 3.117

Review 4.  A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage.

Authors:  David McLeod
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

5.  Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy.

Authors:  Sharif A Issa; Alan Connor; Maged Habib; David Hw Steel
Journal:  Clin Ophthalmol       Date:  2011-01-20

6.  The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy.

Authors:  Abdullah Al-Kharashi; Tural Galbinur; Efrem D Mandelcorn; Rajeev H Muni; Mir Nabavi; Peter J Kertes
Journal:  Saudi J Ophthalmol       Date:  2016-10-29

Review 7.  Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Authors:  Jonathan M Smith; David H W Steel
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.